Dr Richard Keen

Richard Keen graduated from St Mary’s Hospital, London, UK in 1988. After general medical posts in London and Sheffield he started professional training in rheumatology, and during this time developed his specialist interest in osteoporosis. As a research fellow at St. Thomas’ Hospital, London, Richard studied the genetic regulation of postmenopausal osteoporosis, and was awarded Young Investigator awards by the American Society of Bone and Mineral Research (ASBMR) and the European Calcified Tissue Society (ECTS).

Richard Keen is now Director of the Metabolic Bone Disease Unit at the Royal National Orthopaedic Hospital, Stanmore, UK. He also holds a senior lecturer appointment at the Institute of Orthopaedics and Musculoskeletal Science, University College London, London. He heads a clinical research team, and is currently an investigator on several research studies evaluating new treatments for osteoporosis, fracture healing and other metabolic bone disorders. He is the chief investigator for the ZODIAC Study, which is assessing the role for bisphosphonates in the management of bone loss following spinal cord injury. He also heads the VIDEO Study, an arc funded clinical trial examining the effect of vitamin D supplementation on symptomatic knee osteoarthritis.